Publicaciones en colaboración con investigadores/as de University of Glasgow (25)

2024

  1. COVID-19 and cardiovascular disease in patients with chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189

  2. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

    Clinical Kidney Journal, Vol. 17, Núm. 3

2023

  1. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

    JAMA, Vol. 330, Núm. 13, pp. 1266-1277

  2. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

    European heart journal, Vol. 44, Núm. 13, pp. 1157-1166

  3. Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25

  4. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy

    Gut, Vol. 73, Núm. 3, pp. 496-508

  5. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆

    ESMO Open, Vol. 8, Núm. 2

  6. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455

2022

  1. PEGASO e-Diary: User Engagement and Dietary Behavior Change of a Mobile Food Record for Adolescents

    Frontiers in Nutrition, Vol. 9

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (Drugs, (2021), 81, 13, (1467-1489), 10.1007/s40265-021-01555-5)

    Drugs

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    Drugs, Vol. 81, Núm. 13, pp. 1467-1489

  4. Intravenous iron therapy and the cardiovascular system: risks and benefits

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1067-1076

  5. Same rhythm, different song-Approaches to atrial fibrillation management by cardiologists and nephrologists

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 9-13

2020

  1. Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart

    Cardiovascular Drugs and Therapy, Vol. 34, Núm. 6, pp. 823-834

2019

  1. Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)

    Nature Reviews Nephrology

  2. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

    Database, Vol. 2019, pp. 1-67

2018

  1. Lipid management in patients with chronic kidney disease

    Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749

2017

  1. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

    New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239